Peucedanocoumarin III is an inhibitor of (alpha)-synuclein and Huntington protein aggregates that enhances the clearance of nuclear and cytoplasmic beta23 aggregates and prevents cytotoxicity induced by disease-associated proteins (i.e., mutant Huntington proteins and alpha-synuclein). Peucedanocoumarin III may be used in Parkinsons disease research[1].
Molecular Weight:
386.40
Purity:
95.07
CAS Number:
[130464-57-2]
Formula:
C21H22O7
Target:
alpha-synuclein
Application Notes:
Natural Products
* VAT and and shipping costs not included. Errors and price changes excepted
